Other less common side effects may include headaches, dizziness, or tiredness
The category change improves access through licensed pharmacies
Ganju and coauthors commented, Defining the role of GLP-1 RAs in Crohns disease is critical as obesity prevalence rises and integrated care models across gastroenterology, endocrinology, and obesity medicine become more essential. This study included 546 patients with CD with overweight or obesity who had initiated use of a GLP-1RA and were matched with 546 nonGLP-1RA users from the TriNetX research network
There are many products on the market for those who need insulin, but until now, people suffering from a severe hypoglycemic episode had to be treated with a glucagon injection that first had to be mixed in a several-step process, said Janet Woodcock, M.D., director of the FDAs Center for Drug Evaluation and Research
A lot of adults experience increased fatigue, less muscle mass, and slower healing as they get older
Small clinical trials have explored GLP-1 receptor agonists in Parkinson's disease and Alzheimer's disease with modest signals of potential benefit, but definitive evidence is lacking